Economic and reasonable
• Simple synthesis route with few steps
• FDA: The proposed starting material should react multiple steps apart from the final intermediate of the API
• The raw materials are easy to obtain and stable.
• Intermediates are easily separated and stable.
• It is easy to operate and reaches the medicinal standard after separation and purification.
• High yield, low cost and maximum economic benefit
Green, Safe
• No high-risk reaction
• Minimize the generation of Genetic Impurities.
• Less demanding production equipment requirements
• Generate less waste, which is easy to treat